Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.

By M. Roman, B. Shanker, Adrienne Davis, M. Lockshin, L. Sammaritano, R. Simantov, M. Crow, J. Schwartz, S. Paget, R. Devereux and 1 more. New England Journal of Medicine, 2003

1,480 citations recorded by the source corpus.

Subfields: Pathology and Forensic Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/34b1b65f09179c4e2b2b303153b82d9af446126b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

K. Kirou
M. Crow
Christina Lee
Sandhya George
Kyriakos Louca
M. Peterson

Citations in the corpus

Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. (2004, neutral): “Finally, there is an increased incidence of CAD in patients with inflammatory diseases such as rheumatoid arthritis, psoriasis, and systemic lupus erythematosus (243-246).”
Mortality in systemic lupus erythematosus. (2006, neutral): “Classic atherosclerosis risk factors, such as hypertension and hypercholesterolemia, do play a role, although recent work has suggested that additional risk is conferred by some disease-related characteristics, such as SLE duration and, perhaps, severity (26).”
Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. (2005, methodology): “patients were recruited through the HSS Autoimmune Disease Registry, in 2 ways: 1) patients with relatively quiescent disease (n 64) were enrolled in a concurrent study of accelerated atherosclerosis in SLE (22) and were recruited consecutively from October 2002 until March 2004; 2) additional patie”